BeStock  
Stocks › Biotechnology › ZVRA

Zevra Therapeutics ZVRA

US equityMarket cap rank #3557Biotechnology
$11.08 +$0.35 (+3.26%)
Pre-market · Oct 8, 7:00 am ET · After hours $11.19 +0.99%
Open$10.68
Prev close$10.73
Day range$10.57 – $11.38
Volume936.5K
Market cap$657.97M
P/E (TTM)11.9
Dividend yield–

Price chart

Daily bars for up to one year, weekly bars for the 5-year view. Averages are 50/200 trading days (10/40 weeks on the 5-year view). Triangles mark past earnings reports, colored by that day’s move; ticks mark ex-dividend dates — hover either for the date. Volume is the shaded bars under the price; switch on RSI or MACD above for a full-history oscillator panel, or Bollinger Bands for the same 20-day/2-standard-deviation channel used in the Technical signals table.

Technical signals

Trend readLeaning bearish

2 bullish · 5 bearish of 7 signals

IndicatorValueSignalReading
Price vs 20-day average-2.0%BearishTrading below the 20-day average of $11.31
Price vs 50-day average-2.8%BearishTrading below the 50-day average of $11.40
Price vs 200-day average+4.5%BullishTrading above the 200-day average of $10.60
50-day vs 200-day50d above 200dBullishThe 50-day average is above the 200-day average
RSI (14)47.1BearishMomentum leans negative
MACD (12,26,9)-0.30BearishMACD line is below its signal line
Bollinger band position40%BearishInside the 20-day bands

Standard indicator readings worked out from daily closes. They describe how the price has behaved, not where it is going.

Levels & volatility

Moving averages

AverageLevelPrice vs. it
20-day SMA$11.31-2.0%
50-day SMA$11.40-2.8%
200-day SMA$10.60+4.5%

Recent price levels

LevelPrice
20-day high$12.34
20-day low$9.85
60-day high$13.14
60-day low$9.10
Upper Bollinger band$12.48
Lower Bollinger band$10.14

The 50-day average is currently 7.6% above the 200-day average — consistent with a “golden cross” (bullish) configuration.

30-day volatility43.9%
Average true range4.26% of price
Max drawdown (1y)-35.5%
Volume (10d vs 90d)0.81x

Discussion

No comments yet — be the first to weigh in on ZVRA.

Leave a comment

Scroll to Top